Effects of Dexmedetomidine in Combination with Sufentanil - based Intravenous Patient - controlled Analgesia after Video - assisted Thoracoscopic Surgery
10.3969/j.issn.1671-332X.2018.05.045
- VernacularTitle:右美托咪啶对胸腔镜肺部手术后舒芬太尼自控静脉镇痛效果的影响
- Author:
Zhicong ZOU
1
Author Information
1. 嘉应学院医学院附属医院 广东 梅州 514031
- Keywords:
Video-assisted Thoracoscopic Surgery;
Patient-controlled Analgesia;
Sufentanil;
Dexmedetomidine
- From:
Modern Hospital
2018;18(5):763-765
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of dexmedetomidine in combination with sufentanil-based intravenous patient-controlled analgesia. Methods 60 ASA Ⅰ～Ⅱ patients undergoing video-assisted thoracoscopic surgery were divided into two groups (30 patients in each group). In group A, only sufentanil was included in the reagent of patient-controlled analgesia. In group B, dexmedetomidine and sufentanil were included. Results Compared to Group A, consumption of sufentanil in group B at 8h, 24h and 48h after surgery and the incidence of nausea were significantly lower (P＜0.05). The side effects incidences such as vomiting, deep sedation, urine retention and pruritus were comparable between two groups. Conclusion Dexmedetomidine-sufentanil combination for postoperative analgesia in video-assisted thoracoscopic surgery patients resulted in significant sufentanil sparing and lower incidence of nausea.
